Association of electrostimulation with cell transplantation in ischemic heart disease

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 4, 2009, Pages 994-1001

  Shafy, Abdel ^a   Lavergne, Thomas ^a   Latremouille, Christian ^a   Cortes Morichetti, Miguel ^a   Carpentier, Alain ^a   Chachques, Juan C ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSISTED CIRCULATION; CARDIAC RESYNCHRONIZATION THERAPY; CELL DIFFERENTIATION; CELL THERAPY; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROSTIMULATION; EPICARDIUM; FEMALE; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART PACING; HEART VENTRICLE FUNCTION; HEART WORK; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MYOBLAST; MYOTUBE; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPLASTY; CELLS, CULTURED; ECHOCARDIOGRAPHY; FEMALE; INJECTIONS; MYOBLASTS, SKELETAL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; SHEEP; STROKE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 70349160043     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.02.025     Document Type: Article

References (35)

1. McCue J.D., Swingen C., Feldberg T., Caron G., Kolb A., Denucci C., et al. The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J Heart Lung Transplant 27 (2008) 116-123
2. Suuronen E.J., Price J., Veinot J.P., Ascah K., Kapila V., Guo X.W., et al. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg 134 (2007) 1249-1258
3. Chachques J.C., Salanson-Lajos C., Lajos P., Shafy A., Alshamry A., and Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann 13 (2005) 287-296
4. Kan C.D., Li S.H., Weisel R.D., Zhang S., and Li R.K. Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J Am Coll Cardiol 50 (2007) 1086-1092
5. Robey T.E., Saiget M.K., Reinecke H., and Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45 (2008) 567-581
6. Jolicoeur E.M., Granger C.B., Fakunding J.L., Mockrin S.C., Grant S.M., Ellis S.G., et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J 153 (2007) 732-742
7. Chachques J.C., Acar C., Herreros J., Trainini J.C., Prosper F., D'Attellis N., et al. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg 77 (2004) 1121-1130
8. Auricchio A., and Prinzen F.W. Update on the pathophysiological basics of cardiac resynchronization therapy. Europace 10 (2008) 797-800
9. Cazeau S., Alonso C., Jauvert G., Lazarus A., and Ritter P. Cardiac resynchronization therapy. Europace 5 Suppl 1 (2004) S42-S48
10. Nagueh S.F. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol 51 (2008) 18-22
11. Chachques J.C., Abdel Shafy A.B., Duarte F., Cattadori B., Goussef N., Shen L., and Carpentier A. From dynamic to cellular cardiomyoplasty. J Card Surg 17 (2002) 194-200
12. Monnet E., and Chachques J.C. Animal models of heart failure: what is new?. Ann Thorac Surg 79 (2005) 1445-1453
13. Yankey G.K., Li T., Kilic A., Cheng G., Satpute A., Savai K., et al. Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model. J Thorac Cardiovasc Surg 135 (2008) 991-998 998.e1-2
14. Jessup M., and Brozena S.C. Guidelines for the management of heart failure: differences in guideline perspectives. Cardiol Clin 25 (2007) 497-506
15. Cleland J.G., Coletta A.P., Abdellah A.T., Cullington D., Clark A.L., and Rigby A.S. Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. Eur J Heart Fail 10 (2008) 102-108
16. Rajnoch C., Chachques J.C., Berrebi A., Bruneval P., Benoit M.O., and Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 121 (2001) 871-878
17. Chachques J.C., Duarte F., Cattadori B., Shafy A., Lila N., Chatellier G., et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J. Thorac Cardiovasc Surg 128 (2004) 245-253
18. Carvalho K.A., Simeoni R.B., Guarita-Souza L.C., Francisco J.C., Abdelwahid E., Myiague N.I., et al. Angiogenesis without functional outcome after mononuclear stem cell transplant in a doxorubicin-induced dilated myocardiopathy murine model. Int J Artif Organs 31 (2008) 431-438
19. Chachques J.C. Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure?. Eur J Cardiothorac Surg 35 (2009) 201-203
20. Iijima Y., Nagai T., Mizukami M., Matsuura K., Ogura T., Wada H., et al. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J 17 (2003) 1361-1363
21. Mills W.R., Mal N., Kiedrowski M.J., Unger R., Forudi F., Popovic Z.B., et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 42 (2007) 304-314
22. Carraro U. Long-term aneurally regenerated skeletal myofibers into heart: how long they could survive and grow by phasic daily FES?. Basic Appl Myol 13 (2003) 53-63
23. Genovese J.A., Spadaccio C., Chachques E., Schussler O., Carpentier A., Chachques J.C., and Patel A.N. Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Fron Biosci 14 (2009) 2996-3002
24. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogle M.E., Wang J.A., and Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135 (2008) 799-808
25. Memon I.A., Sawa Y., Miyagawa S., Taketani S., and Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 130 (2005) 646-653
26. Cortes-Morichetti M., Frati G., Schussler O., Van Huyen J.P., Lauret E., et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 13 (2007) 2681-2687
27. Chachques J.C., Trainini J.C., Lago N., Cortes-Morichetti M., Schussler O., and Carpentier A. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg 85 (2008) 901-908
28. Schussler O., Coirault C., Louis-Tisserand M., Al Chare W., Oliviero P., Menard C., et al. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Pract Cardiovasc Med 6 (2009) 240-249
29. Conti J.B., and Sears S.F. Cardiac resynchronization therapy: can we make our heart failure patients smarter?. Trans Am Clin Climatol Assoc 118 (2007) 153-164
30. Young J.B., Abraham W.T., Smith A.L., Leon A.R., Lieberman R., Wilkoff B., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289 (2003) 2685-2694
31. Doll N., Piorkowski C., Czesla M., Kallenbach M., Rastan A.J., Arya A., and Mohr F.W. Epicardial versus transvenous left ventricular lead placement in patients receiving cardiac resynchronization therapy: results from a randomized prospective study. Thorac Cardiovasc Surg 56 (2008) 256-261
32. Rademakers L.M., de Boeck B.W., Maessen J.G., and Prinzen F.W. Development of strategies for guiding cardiac resynchronization therapy. Heart Fail Clin 4 (2008) 333-345
33. Fauchier L., Poret P., Robin I., de Labriolle A., Giraudeau C., Cosnay P., and Babuty D. Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 97 (2006) 393-399
34. de Sisti A., Toussaint J.F., Lavergne T., Ollitrault J., Abergel E., Paziaud O., et al. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization. Pacing Clin Electrophysiol 28 (2005) 1260-1270
35. Atoui R., Shum-Tim D., and Chiu R.C. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells.". Ann Thorac Surg 86 (2008) 327-334